Special article: Future directions in malignant hyperthermia research and patient care.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21709147.
- Also identified by DOI 10.1213/ANE.0b013e318222af2e and PMC identifier 3184381.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malignant hyperthermia (MH) is a complex pharmacogenetic disorder of muscle metabolism. To more closely examine the complexities of MH and other related muscle disorders, the Malignant Hyperthermia Association of the United States (MHAUS) recently sponsored a scientific conference at which an interdisciplinary group of experts gathered to share new information and ideas. In this Special Article, we highlight key concepts and theories presented at the conference along with exciting new trends and challenges in MH research and patient care.
Medical subject headings
- Malignant Hyperthermia